当前位置： SCI文献检索 > EUROPEAN UROLOGY期刊下所有文献 > The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers.

The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers.

Abstract：

:The European Randomized study of Screening for Prostate Cancer (ERSPC) has shown a 20% relative reduction in prostate cancer mortality after 16yr [rate ratio (RR) 0.80], but centers varied by attendance, screen interval, biopsy compliance, contamination in the control arm, and treatments. We used a microsimulation model, calibrated to the ERSPC individual-level data, to predict influence of study features on the results. The relative reduction in prostate cancer mortality would have been somewhat larger with improved study features: increased attendance (90% attendance in all volunteer-based and 70% in all population-based centers, resulting in RR 0.77), a 2-yr screen interval (RR 0.75), and an 80% biopsy compliance (RR 0.79). The RR would have been substantially lower with a 30% attendance (RR 0.92), 40% biopsy compliance (RR 0.90), or 100% contamination (RR 0.85). The variations in results by trial center may reflect differences in study design and performance and results of our simulations highlight the effect of quality indicators in prostate-specific antigen screening in different settings. PATIENT SUMMARY: We evaluated the effect of various features of prostate-specific antigen (PSA) screening on its effectiveness. The compliance to PSA testing and those having a biopsy after an elevated PSA substantially influence the prostate cancer mortality.

journal_name

Eur Urol

journal_title

European urology

authors

Heijnsdijk EAM,Adolfsson J,Auvinen A,Roobol MJ,Hugosson J,de Koning HJ

doi

10.1016/j.eururo.2019.04.007

subject

Has Abstract

pub_date

2019-09-01 00:00:00

pages

276-279

issue

3

eissn

0302-2838

issn

1873-7560

pii

S0302-2838(19)30286-6

journal_volume

76

pub_type

杂志文章,评审

相关文献

EUROPEAN UROLOGY文献大全
  • Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic obstruction (symptomatic BPH). European Tam

    abstract：OBJECTIVE:This open-label extension study evaluated the efficacy and safety of tamsulosin (0.4 mg as a modified release formulation) once daily in patients with benign prostatic enlargement, lower urinary tract symptoms and benign prostatic obstruction (symptomatic BPH) for up to 60 weeks. METHODS:Patients were enroll...

    journal_title：European urology

    pub_type： 临床试验,杂志文章,多中心研究,随机对照试验

    doi：

    authors： Schulman CC,Cortvriend J,Jonas U,Lock TM,Vaage S,Speakman MJ

    更新日期：1996-01-01 00:00:00

  • Complexed prostate specific antigen density is better than the other PSA derivatives for detection of prostate cancer in men with total PSA between 2.5 and 20 ng/ml: results of a prospective multicenter study.

    abstract：PURPOSE:This prospective, multicenter study was initiated to evaluate the diagnostic performance of PSA, free/total PSA (f/tPSA) and complexed PSA (cPSA) with volume-based parameters for early detection of prostate cancer in patients with PSA between 2.5 and 20 ng/ml. MATERIALS AND METHODS:408 subjects with serum PSA ...

    journal_title：European urology

    pub_type： 临床试验,杂志文章,多中心研究

    doi：10.1016/j.eururo.2004.10.009

    authors： Sözen S,Eskicorapci S,Küpeli B,Irkilata L,Altinel M,Ozer G,Uygur C,Alkibay T,Ozen H

    更新日期：2005-03-01 00:00:00

  • Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer.

    abstract：BACKGROUND:Active surveillance (AS) has been proposed as an effective strategy to reduce overtreatment among men with lower risk prostate cancers. However, historical rates of initial surveillance are low (4-20%), and little is known about its application among community-based urology practices. OBJECTIVE:To describe ...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2014.08.024

    authors： Womble PR,Montie JE,Ye Z,Linsell SM,Lane BR,Miller DC,Michigan Urological Surgery Improvement Collaborative.

    更新日期：2015-01-01 00:00:00

  • Perioperative morbidity of the extended radical perineal prostatectomy.

    abstract：PURPOSE:Perioperative morbidity is an essential indicator for the quality of an operative technique. This fact is especially important in radical prostatectomy since different treatment modalities may provide similar outcome in terms of local tumor control. MATERIALS AND METHODS:The conventional type of radical perine...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000049764

    authors： Brehmer B,Borchers H,Kirschner-Hermanns R,Biesterfeld S,Jakse G

    更新日期：2001-08-01 00:00:00

  • Effects of prostaglandin E2 applied locally on intravesical and intraurethral pressures in women.

    abstract：:In 21 women undergoing simultaneous urethrocystometry because of dysuria, urge, and difficulties to empty the bladder, the effects of prostaglandin E2 (PGE2) applied locally in the bladder and urethra were investigated. In all 9 patients receiving PGE2 intravesically, the bladder pressure increased. Simultaneously, th...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000473995

    authors： Andersson KE,Henriksson L,Ulmsten U

    更新日期：1978-01-01 00:00:00

  • Laparoscopic radical prostatectomy: prospective evaluation of the learning curve.

    abstract：OBJECTIVE:We prospectively evaluated the learning curve (LC) of laparoscopic radical prostatectomy (L-RPE) regarding the improvements in operative times (OT) and technical difficulty in one-operator-practice as it compares with open RPE. METHODS:Over 18 months, 50 L-RPE were performed by an inexperienced surgeon in la...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2004.09.006

    authors： Poulakis V,Dillenburg W,Moeckel M,de Vries R,Witzsch U,Zumbé J,Rassweiler J,Becht E

    更新日期：2005-02-01 00:00:00

  • ETS gene fusions in prostate cancer: from discovery to daily clinical practice.

    abstract：CONTEXT:In 2005, fusions between the androgen-regulated transmembrane protease serine 2 gene, TMPRSS2, and E twenty-six (ETS) transcription factors were discovered in prostate cancer. OBJECTIVE:To review advances in our understanding of ETS gene fusions, focusing on challenges affecting translation to clinical applica...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2009.04.036

    authors： Tomlins SA,Bjartell A,Chinnaiyan AM,Jenster G,Nam RK,Rubin MA,Schalken JA

    更新日期：2009-08-01 00:00:00

  • Anticholinergic Burden in the Elderly Population: An Emerging Concern.

    abstract：:Antimuscarinics are commonly used to treat overactive bladder, but increase anticholinergic burden, which has been associated with multiple adverse outcomes in older patients. We advocate for standardization of anticholinergic risk assessment and reevaluation of anticholinergic prescribing practices for the elderly. ...

    journal_title：European urology

    pub_type： 社论

    doi：10.1016/j.eururo.2019.03.021

    authors： Pierce H,Thomas D,Asfaw T,Chughtai B

    更新日期：2019-07-01 00:00:00

  • Prediction of functional outcomes after nerve-sparing radical prostatectomy: results of conditional survival analyses.

    abstract：BACKGROUND:In prostate cancer (PCa) patients treated with radical prostatectomy (RP), the rate of urinary continence (UC) and erectile function (EF) recovery may change significantly depending on the time interval between surgery and patient assessment. This effect, known as conditional survival, has not yet been asses...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2012.02.057

    authors： Abdollah F,Sun M,Suardi N,Gallina A,Bianchi M,Tutolo M,Passoni N,Tian Z,Salonia A,Colombo R,Rigatti P,Karakiewicz PI,Montorsi F,Briganti A

    更新日期：2012-07-01 00:00:00

  • Beckwitt-Wiedemann's syndrome with medullary sponge kidneys, agonadism and persistent testosterone production.

    abstract：:A patient with Beckwitt-Wiedemann's syndrome is described in which associated malformations were hemihypertrophy of the body, medullary sponge kidneys and absence of testes and internal ducts. On the other hand, we demonstrated biochemically the existence of testosterone secretion, with active response to a 3-day HCG ...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000472070

    authors： Salgado AL,Macia AL,Freire A,Paramo P,Fernandez-Cruz A

    更新日期：1977-01-01 00:00:00

  • A new prostatic stent for the treatment of benign prostatic hyperplasia in high-risk patients.

    abstract：OBJECTIVES:The objective of this study was to evaluate the efficacy and safety of a new prostatic stent (Trestle((R)), Boston Scientific Microvasive) for the treatment of BPH in patients with complete urinary retention and considered to be inoperable. METHODS:The efficacy of the stent was evaluated in terms of return ...

    journal_title：European urology

    pub_type： 临床试验,杂志文章

    doi：10.1159/000020293

    authors： Traxer O,Anidjar M,Gaudez F,Saporta F,Daudon M,Cortesse A,Desgrandchamps F,Cussenot O,Teillac P,Le Duc A

    更新日期：2000-09-01 00:00:00

  • The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer.

    abstract：OBJECTIVES:Pelvic lymph node metastases indicate a poor prognosis for patients with clinically localized prostate cancer. The aim of the study was to investigate the value of extended histopathological techniques considering the extent of pelvic lymphadenectomy and preoperative risk factors. METHODS:Total of 194 patie...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/s0302-2838(02)00450-5

    authors： Wawroschek F,Wagner T,Hamm M,Weckermann D,Vogt H,Märkl B,Gordijn R,Harzmann R

    更新日期：2003-02-01 00:00:00

  • Ultrasound-guided biopsy of homogenous solid renal masses.

    abstract：OBJECTIVES:We evaluated the reliability of sonographic criteria in selecting solid renal masses for percutaneous fine-needle biopsy. METHODS:In study 1 (intraoperative ultrasound study), we prospectively examined 100 consecutive patients scheduled for partial/radical nephrectomy by using two different high-resolution ...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2007.01.078

    authors： Reichelt O,Gajda M,Chyhrai A,Wunderlich H,Junker K,Schubert J

    更新日期：2007-11-01 00:00:00

  • Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti-PD-1 Immune Checkpoint Inhibitors.

    abstract：:Preclinical models and early clinical data suggest an interplay between the gut microbiome and response to immunotherapy in solid tumors including metastatic renal cell carcinoma (mRCC). We sought to characterize the stool microbiome of mRCC patients receiving a checkpoint inhibitor (CPI) and to assess treatment-relat...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2020.07.011

    authors： Salgia NJ,Bergerot PG,Maia MC,Dizman N,Hsu J,Gillece JD,Folkerts M,Reining L,Trent J,Highlander SK,Pal SK

    更新日期：2020-10-01 00:00:00

  • Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials.

    abstract：CONTEXT:The role of adjuvant chemotherapy remains poorly defined for the management of muscle-invasive bladder cancer (MIBC). The last meta-analysis evaluating adjuvant chemotherapy, conducted in 2005, had limited power to fully support its use. OBJECTIVE:To update the current evidence of the benefit of postoperative ...

    journal_title：European urology

    pub_type： 杂志文章,meta分析,评审

    doi：10.1016/j.eururo.2013.08.033

    authors： Leow JJ,Martin-Doyle W,Rajagopal PS,Patel CG,Anderson EM,Rothman AT,Cote RJ,Urun Y,Chang SL,Choueiri TK,Bellmunt J

    更新日期：2014-07-01 00:00:00

  • Who should be treated and how? Evidence-based medicine in symptomatic BPH.

    abstract：:The management of benign prostatic hyperplasia (BPH), although based on the best available evidence, should be individualised to patients' circumstances and personal choices. Subjective symptoms (LUTS), bothersomeness and negative impact on the quality of life are the main reasons for the patient to seek treatment for...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000052348

    authors： Speakman MJ

    更新日期：1999-01-01 00:00:00

  • Melanosis (pigmented melanocytosis) of the prostate gland.

    abstract：:A case of stromal melanosis of the prostate gland is reported. Ultrastructurally, dendritic processes and melanosomes, but no basal lamina were observed in melanin-containing cells. In similar cases, characterized by the diffuse distribution of stromal pigmented melanocytes, the term 'pigmented melanocytosis' rather t...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000471576

    authors： Botticelli AR,Di Gregorio C,Losi L,Fano RA,Manenti A

    更新日期：1989-01-01 00:00:00

  • Pharmacokinetic profile of fosfomycin trometamol (Monuril).

    abstract：:The kinetics of fosfomycin in serum and in urine was studied in 5 healthy volunteers after intravenous administration of disodium fosfomycin and after oral administration of trometamol fosfomycin at 50 mg/kg. The presence of secondary peaks in serum kinetics, more evident after oral administration, requires the use of...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000472864

    authors： Segre G,Bianchi E,Cataldi A,Zannini G

    更新日期：1987-01-01 00:00:00

  • Cytokeratin-20 reverse-transcriptase polymerase chain reaction as a new tool for the detection of circulating tumor cells in peripheral blood and bone marrow of bladder cancer patients.

    abstract：OBJECTIVES:Systemic progression is the prevalent form of bladder tumor recurrence after radical cystectomy. The ability to detect circulating tumor cells in peripheral blood or bone marrow could be of prognostic value for the disease with the consequence of early adjuvant chemotherapy. We established a sensitive and sp...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000052496

    authors： Retz M,Lehmann J,Röder C,Weichert-Jacobsen K,Loch T,Romahn E,Lühl C,Kalthoff H,Stöckle M

    更新日期：2001-05-01 00:00:00

  • Nonrefluxing colonic conduit: efficiency and complications of ureterocolic anastomosis.

    abstract：:The efficiency of and complications in 65 cases of colonic conduit have been studied (64 cases of bladder exstrophy and 1 case of cloacal exstrophy). For the ureterocolic reimplantation, we employed the Leadbetter technique and a modified kelalis technique. The results after 1-12 years in 128 renoureteral units showed...

    journal_title：European urology

    pub_type： 杂志文章

    doi：

    authors： Arap S,Giron AM,Abrão EG,Mitre AI,Menezes de Góes G

    更新日期：1982-01-01 00:00:00

  • The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basic science and clinical data.

    abstract：OBJECTIVES:To assess the usefulness of the phosphodiesterase type 5 inhibitors (PDE5-Is) in the treatment of premature ejaculation (PE) and to describe possible mechanisms to explain their effect. METHODS:A MedLine search was performed for peer-reviewed articles on the role of PDE5-Is in managing PE. No meta-analysis ...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2007.08.005

    authors： Chen J,Keren-Paz G,Bar-Yosef Y,Matzkin H

    更新日期：2007-11-01 00:00:00

  • Predictive value of pathological features for progression after radical prostatectomy.

    abstract：OBJECTIVE:10-30% of patients with T1/T2 prostate cancer submitted to radical prostatectomy ultimately fail. It may be important to detect failure as early as possible in order to evaluate the extent of recurrent/residual disease and initiate adjuvant therapy. SUBJECTS AND METHODS:100 consecutive patients with localize...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000475379

    authors： Ravery V,Boccon-Gibod LA,Meulemans A,Dauge-Geffroy MC,Toublanc M,Boccon-Gibod L

    更新日期：1994-01-01 00:00:00

  • Renal angiomyolipoma. A report of 11 cases.

    abstract：:Renal angiomyolipomas are benign mesenchymal tumours. Whether isolated or associated with phacomatosis, they are histologically identical, but it is often difficult to distinguish an isolated angiomyolipoma from renal cancer. When it is combined with phacomatosis, it is frequently bilateral and can provoke retroperito...

    journal_title：European urology

    pub_type： 杂志文章

    doi：

    authors： Mazeman E,Wemeau L,Biserte J,Riquet D

    更新日期：1980-01-01 00:00:00

  • Ileal orthotopic bladder substitute combined with an afferent tubular segment: long-term upper urinary tract changes and voiding pattern.

    abstract：OBJECTIVE:Assessment of the long-term morbidity of the upper urinary tract and of the voiding pattern in men with an ileal orthotopic bladder substitute with an afferent tubular segment. MATERIALS AND METHODS:Men surviving more than 5 years after radical cystectomy and orthotopic bladder substitution were evaluated. T...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2004.07.009

    authors： Perimenis P,Burkhard FC,Kessler TM,Gramann T,Studer UE

    更新日期：2004-11-01 00:00:00

  • Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.

    abstract：OBJECTIVE:To investigate possible changes in the expression of the transient receptor potential vanilloid type 1 (TRPV1) from normal urothelium to transitional cell carcinoma (TCC) of human bladder. METHODS:Specimens from normal bladder (n=13, mean age 62 yrs), superficial TCC (n=16, mean age 62,4 yrs) and muscle inva...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1016/j.eururo.2005.05.018

    authors： Lazzeri M,Vannucchi MG,Spinelli M,Bizzoco E,Beneforti P,Turini D,Faussone-Pellegrini MS

    更新日期：2005-10-01 00:00:00

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.

    abstract：CONTEXT:This overview presents the updated European Association of Urology (EAU) guidelines for non-muscle-invasive bladder cancer (NMIBC), TaT1, and carcinoma in situ (CIS). OBJECTIVE:To provide practical recommendations on the clinical management of NMIBC with a focus on clinical presentation and recommendations. E...

    journal_title：European urology

    pub_type： 杂志文章,评审

    doi：10.1016/j.eururo.2019.08.016

    authors： Babjuk M,Burger M,Compérat EM,Gontero P,Mostafid AH,Palou J,van Rhijn BWG,Rouprêt M,Shariat SF,Sylvester R,Zigeuner R,Capoun O,Cohen D,Escrig JLD,Hernández V,Peyronnet B,Seisen T,Soukup V

    更新日期：2019-11-01 00:00:00

  • Does internal urethrotomy prevent urethral stricture after transurethral prostatectomy. Early and late results.

    abstract：:In a randomized study of 200 consecutive patients undergoing transurethral prostatectomy (TURP), the combination of internal urethrotomy and TURP (the trial group) was compared with TURP alone (the control group) with regard to the development of urethral strictures postoperatively. Three months after resection, 14% i...

    journal_title：European urology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1159/000471587

    authors： Nielsen KK,Kjoergaard B,Kristensen ES,Jeppesen L,Krarup T

    更新日期：1989-01-01 00:00:00

  • Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard.

    abstract：:Addition of docetaxel to androgen deprivation therapy (ADT) was recommended for patients with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC), who are fit enough to receive docetaxel. Two recently published trials showed that the addition of abiraterone acetate plus prednisone to ADT has a clear s...

    journal_title：European urology

    pub_type： 社论

    doi：10.1016/j.eururo.2017.09.029

    authors： Mottet N,De Santis M,Briers E,Bourke L,Gillessen S,Grummet JP,Lam TB,van der Poel HG,Rouvière O,van den Bergh RCN,Cornford P

    更新日期：2018-03-01 00:00:00

  • Aminoglutethimide for advanced prostatic cancer resistant to conventional hormonal therapy.

    abstract：:Aminoglutethimide (AG) and hydrocortisone (HC) were given to 20 patients with advanced prostatic cancer resistant to conventional hormonal therapy. Most patients had painful bone metastases and were heavily pretreated. 12 of 16 patients required narcotic analgetics. 8 of 20 were bedridden. AG + HC produced relief of b...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000472913

    authors： Elomaa I,Taube T,Blomqvist C,Rissanen P,Rannikko S,Alfthan O

    更新日期：1988-01-01 00:00:00

  • Shock wave lithotripsy treatment of radiolucent ureteric calculi with the help of contrast medium.

    abstract：OBJECTIVE:Extracorporeal shock wave lithotripsy (SWL) treatment of radiolucent ureteric calculi (UC) is hampered by the reduced visibility of the stone. Intravenous contrast medium (IV-CM) administration may overcome this problem by indirectly depicting the localisation of the stone. However, IV-CM administration bears...

    journal_title：European urology

    pub_type： 杂志文章

    doi：10.1159/000052436

    authors： Buchholz NP,van Rossum M

    更新日期：2001-02-01 00:00:00